立体定向消融放疗治疗寡转移疾病：仅仅是数字游戏吗？ - Suppr

Suppr

超能文献

Treating Oligometastatic Disease With SABR: More Than Just a Numbers Game?

作者信息

Chang Daniel T, Pollom Erqi L, Keane Florence K, Wo Jennifer Y

机构信息

Department of Radiation Oncology, Stanford Cancer Institute, Stanford, California.

出版信息

Int J Radiat Oncol Biol Phys. 2020 Jun 1;107(2):257-260. doi: 10.1016/j.ijrobp.2020.02.018.

DOI:10.1016/j.ijrobp.2020.02.018

PMID:32386736

Abstract

摘要

相似文献

Treating Oligometastatic Disease With SABR: More Than Just a Numbers Game?

Int J Radiat Oncol Biol Phys. 2020 Jun 1;107(2):257-260. doi: 10.1016/j.ijrobp.2020.02.018.

Stereotactic radiotherapy in oligometastatic cancer.

Chin Clin Oncol. 2017 Sep;6(Suppl 2):S16. doi: 10.21037/cco.2017.06.20.

Radiation therapy for oligometastatic non-small cell lung cancer.

Cancer Metastasis Rev. 2015 Jun;34(2):183-93. doi: 10.1007/s10555-015-9559-z.

Radiotherapy as metastasis-directed therapy for oligometastatic prostate cancer.

Curr Opin Urol. 2017 Nov;27(6):587-595. doi: 10.1097/MOU.0000000000000441.

Stereotactic ablative radiation therapy for oligometastatic prostate cancer delays time-to-next systemic treatment.

World J Urol. 2019 Dec;37(12):2623-2629. doi: 10.1007/s00345-018-2477-2. Epub 2018 Sep 6.

Quality of Life Outcomes After Stereotactic Ablative Radiation Therapy (SABR) Versus Standard of Care Treatments in the Oligometastatic Setting: A Secondary Analysis of the SABR-COMET Randomized Trial.

Int J Radiat Oncol Biol Phys. 2019 Dec 1;105(5):943-947. doi: 10.1016/j.ijrobp.2019.08.041. Epub 2019 Aug 27.

Stereotactic ablative radiotherapy for the comprehensive treatment of 1-3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial.

BMC Cancer. 2020 May 5;20(1):380. doi: 10.1186/s12885-020-06876-4.

A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS).

BMC Cancer. 2020 Jun 1;20(1):492. doi: 10.1186/s12885-020-07000-2.

Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO).

Crit Rev Oncol Hematol. 2019 Jun;138:24-28. doi: 10.1016/j.critrevonc.2019.03.014. Epub 2019 Apr 1.

Local Therapy Indications in the Management of Patients with Oligometastatic Non-Small Cell Lung Cancer.

Surg Oncol Clin N Am. 2016 Jul;25(3):611-20. doi: 10.1016/j.soc.2016.02.007.

引用本文的文献

Local Therapies in Oligometastatic and Oligoprogressive Prostate Cancer.

Semin Radiat Oncol. 2021 Jul;31(3):242-249. doi: 10.1016/j.semradonc.2021.03.007.

Metastases-directed Radiotherapy in Addition to Standard Systemic Therapy in Patients with Oligometastatic Breast Cancer: Study protocol for a randomized controlled multi-national and multi-center clinical trial (OLIGOMA).

Clin Transl Radiat Oncol. 2021 Apr 5;28:90-96. doi: 10.1016/j.ctro.2021.03.012. eCollection 2021 May.

The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited.

Eur Urol. 2021 Nov;80(5):632-640. doi: 10.1016/j.eururo.2020.12.040. Epub 2021 Jan 6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验